Home Page News Statistics API Review Formulation Monthly Im&Ex report All Information
     
Keyword:
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
　　Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Conference on ...
Information Release...
Internationalization&nbs...
Welcome to Pro...
Healthoo.com Carbap...
APIs Innovation&nbs...
China Import Export Statistics Report In...
API Export Price by ...
Tylosin Bulk Drug Export&...
China Monthly Export Stat...
China Monthly Export Stat...
China Monthly Export Stat...
Your position:www.healthoo.com >> EN >> Industry
Chinese vaccine industry will develop with rapid growth2010-10-25
Huazhong Pharma will soon begin Vitamin B6 supplying2010-10-21
HIV-infected persons in China to reach 800,0002010-10-20
SFDA warns diabetics of possible rosiglitazone risk2010-10-18
Exchange rate puts impress on export price of large volume APIs2010-10-14
Average costs of inpatients for 30 diseases in 2009 in China2010-10-14
One large pharmaceutical industrial park settles Sichuan2010-10-13
Sihuan Pharma plans to launch IPO in Hong Kong2010-10-13
ShangPharma planned $90 Million IPO in USA2010-10-12
SFDA requires CTD format application dossiers for drugs2010-10-12
New chemical API item locates in Pengze2010-10-11
China tightens restrictions on online transactions of drug precursor chemicals2010-10-08
SFDA releases 2009 annual report of drug registration approval2010-10-08
Huifeng Bio-Pharma was awarded GMP certificate2010-09-25
China lures global drug makers2010-09-21
Phase III trials of Icotinib finished for NSCLC2010-09-20
Pfizer and MSD launched new dosage form in China2010-09-17
J&J sees double-digit growth in R&D investment in China2010-09-17
Butylphthalide injection (NBP) marketed in China for stroke2010-09-16
Novo Nordisk aims to double R&D staff in China2010-09-15
Bridgehead forms partnership to provide services to Chinese clients2010-09-13
Roche to boost China headcount by 25%2010-09-10
China will be 3rd biggest pharmaceutical market in next 3 years2010-09-09
Capacity of L-carnitine in China expands in recent years2010-09-08
More than 20 producers of finished drugs passed EU or FDA authentication in China2010-09-07
922.4 thousand medical organizations in China up to July2010-09-02
The largest production base of antitumor agents launch Shanxi2010-08-31
VC manufacturers suspend price offering2010-08-26
Phase IIb trial of Sifuvirtide gets positive result in China2010-08-17
Export value of Chinese plant extracts increases steadily2010-08-16
TCM going global with new alliance2010-08-13
New Potassium Clavulanate project started construction2010-08-12
共1471个 页次:27/46页 32个/页 首页 上一页 下一页 尾页 转到：
Our Advantages of Reports
①All reports written by ourselves
②All data having original sources
③Information is the latest
④Continuous historical data
⑤Objective analysis and remark
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
②Transfer payment to company's bank account
③After accepting payment we email the report to clients (PDF format)
④Send the invoice
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
②Beneficiary's Account No.:110060239018002127366
③Name of bank:Bank of Communications Beijing Branch，Fuwai Sub-Branch
④Address of bank:NO7，FUWAISTREET，XICHENG DISTRICT，BEIJING，CHINA SWIFT CODE：COMMCNSHBJG
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463